Stanford | Cambridge | Asilomar | Oxford
Stanford | Cambridge | Asilomar | Oxford
The BrainMind Ecosystem is a collective of top brain scientists, entrepreneurs, investors, philanthropists, and other doers and thinkers to advance ideas in neuroscience, psychology, brain health and vibrancy, optimized learning, and other cutting-edge BrainMind topics. This unique group is patient, risk tolerant, and passionate about the brain, in addition to being at the pinnacle of their respective fields.
Because creating innovative ideas and companies in neuroscience takes a long time and an enormous amount of capital, it will require a special group with a new type of investing philosophy to move the field. To this end, the BrainMind Ecosystem is coordinating around roadmapping the future of the field and from that roadmap, is catalyzing impactful ideas with talent and funding.
We believe cooperation between the right people will accelerate the pace of innovation in neuroscience.
BrainMind is building a collaborative roadmap for effective forward progress in the science of the brain and mind with top scientists and leaders in the field. Special attention will be placed on identifying the challenges that are not well addressed by current government, corporate and venture capital funding.
Within this wider roadmap, we are surfacing researchers, teams, and companies working on impactful ideas that address these challenges.
The Ecosystem then energizes these ideas by infusing them with capital from leaders in the entrepreneurial, investing, and philanthropic communities. Specifically, these funders are aiming to ferry these pivotal ideas across the shortfall in funding for high-risk ideas that outgrow the lab, or the “valley of death”.
BrainMind is cultivating conscientious leadership and investment in the science of brain and mind. This organization is convening invite-only events hosted in collaboration with the world’s pre-eminent neuroscience research institutions. Participants include accomplished entrepreneurs, select investors from venture capital and foundations, respected thought leaders, and esteemed researchers from mind-focused fields. Attendees are engaged in dialogue on the state of the field and brought together to thoughtfully apply the most important findings in mind and brain science.
Within our wider roadmap, BrainMind is surfacing and focusing special attention on ideas that are underfunded in relation to their importance. Examples include:
Prevention, Wellness, and Human Flourishing
Circuit-mapping in the brain
Large-scale efforts to generate and share data
High risk / high return, non-venturable but sustainable, capital- or time-intensive ideas with high potential impact on public health
Over $33 billion dollars are donated annually to healthcare causes, much of which goes to basic research at universities. Government grants amount to over $72 billion annually for basic scientific and medical research. At the other end of the spectrum, venture capital invests $10 billion in healthcare companies. While basic research and commercial companies with high expected returns are funded readily, a "valley of death" of investment separates promising research from mass-scale innovations, especially for ideas that promise significant health impact but modest financial gain. BrainMind seeks to coordinate capital across philanthropy and venture capital to deliver stewardship of fundamental neuroscience to impact-focused stakeholders.
Today, a global network of scientists, engineers, and clinicians are doing tremendous work to uncover the underlying mechanisms of cognition, motivation, learning, memory, sleep, attachment, resilience, neurological disorders, and the process by which consciousness arises. The neurological underpinnings of the human mind are being explored in the nation’s most prestigious institutions, with the creation of multiple centers of excellence for these academic pursuits at Harvard, MIT, Stanford, Oxford, and many more.
Just as the scientific community has made significant strides in neurobiological research with the advent of fMRI, the medical community is converging on transformative discoveries of the phsyical and psychological impact of the human mind. The human mind is also being studied in the context of real-life interventions, including medical, personal, and social approaches. These practices are being studied for applications in stress and anxiety management, cognitive behavioral therapy, stroke recovery, chronic pain management, cancer treatment, child self-regulation, and more.
By exploring the intersection of brain and mind, we gain insight not only into the mechanisms by which the mind affects the brain and the body, but into consciousness itself. By convening the world’s top thinkers, researchers, and innovators on the convergence of neuroscience and the study of human consciousness, we open the door to collaborations and discoveries that will quicken the pace of innovation. The BrainMind team is uniquely equipped to execute on this strategy, with experience in medicine, social entrepreneurship, venture capital, and donor development.
(Photos from the 2016 BrainMind Summit, co-hosted by the Stanford Department of Psychiatry and Behavioral Sciences)